S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
The single greatest medical breakthrough of all time? (Ad)
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
Canadian autoworkers ratify new labor agreement with Ford
The single greatest medical breakthrough of all time? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
The single greatest medical breakthrough of all time? (Ad)
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
Canadian autoworkers ratify new labor agreement with Ford
The single greatest medical breakthrough of all time? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
The single greatest medical breakthrough of all time? (Ad)
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
Canadian autoworkers ratify new labor agreement with Ford
The single greatest medical breakthrough of all time? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
The single greatest medical breakthrough of all time? (Ad)
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
Canadian autoworkers ratify new labor agreement with Ford
The single greatest medical breakthrough of all time? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
NASDAQ:AXGN

AxoGen (AXGN) Earnings Date, Estimates & Call Transcripts

$4.85
-0.14 (-2.81%)
(As of 09/22/2023 ET)
Compare
Today's Range
$4.63
▼
$5.01
50-Day Range
$4.85
▼
$8.95
52-Week Range
$4.63
▼
$13.66
Volume
575,720 shs
Average Volume
231,283 shs
Market Capitalization
$208.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.50
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Nov. 14Estimated
Actual EPS
(Aug. 7)
-$0.16 Beat By $0.07
Consensus EPS
(Aug. 7)
-$0.23
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

AXGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AXGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

AxoGen Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20231($0.51)($0.51)($0.51) 
Q2 20231($0.51)($0.51)($0.51) 
Q3 20231($0.45)($0.45)($0.45) 
Q4 20231($0.21)($0.21)($0.21) 
FY 20234($1.68)($1.68) ($1.68)

AXGN Earnings Date and Information

AxoGen last posted its earnings data on August 7th, 2023. The medical equipment provider reported ($0.16) earnings per share for the quarter, topping analysts' consensus estimates of ($0.23) by $0.07. The company had revenue of $38.16 million for the quarter, compared to analysts' expectations of $39.40 million. AxoGen has generated ($0.56) earnings per share over the last year (($0.56) diluted earnings per share). Earnings for AxoGen are expected to grow in the coming year, from ($0.63) to ($0.41) per share. AxoGen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 14th, 2023 based off prior year's report dates.

AxoGen Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/14/2023
Estimated)		------- 
8/7/2023Q2 2023($0.23)($0.16)+$0.07($0.16)$39.40 million$38.16 million
5/9/2023Q1 2023($0.25)($0.17)+$0.08($0.17)$35.80 million$36.66 million
3/14/2023Q4 2022($0.19)($0.13)+$0.06($0.13)$36.10 million$36.20 million
11/8/2022Q3 2022($0.15)($0.01)+$0.14$0.08$36.10 million$36.96 million
8/3/2022Q2 2022($0.15)($0.06)+$0.09$0.06$32.80 million$34.45 million      
5/4/2022Q1 2022($0.23)($0.26)($0.03)($0.25)$30.40 million$31.01 million    
2/22/2022Q4 2021($0.18)($0.12)+$0.06($0.11)$31.50 million$31.54 million    
11/2/2021Q3 2021($0.14)($0.09)+$0.05($0.15)$34.65 million$31.20 million    
8/3/2021Q2 2021($0.13)($0.09)+$0.04($0.17)$32.30 million$33.58 million    
5/4/2021Q1 2021($0.20)($0.08)+$0.12($0.14)$28.65 million$31.04 million    
2/21/2021Q4 2020($0.16)($0.08)+$0.08($0.15)$32.40 million$32.50 million  
11/3/2020Q3 2020($0.14)$0.04+$0.18($0.04)$30.10 million$33.43 million  












AxoGen Earnings - Frequently Asked Questions

When is AxoGen's earnings date?

AxoGen has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 14th, 2023 based off last year's report dates. Learn more on AXGN's earnings history.

Did AxoGen beat their earnings estimates last quarter?

In the previous quarter, AxoGen (NASDAQ:AXGN) reported ($0.16) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.07. Learn more on analysts' earnings estimate vs. AXGN's actual earnings.

How much revenue does AxoGen generate each year?

AxoGen (NASDAQ:AXGN) has a recorded annual revenue of $138.58 million.

How much profit does AxoGen generate each year?

AxoGen (NASDAQ:AXGN) has a recorded net income of -$28.95 million. AXGN has generated -$0.56 earnings per share over the last four quarters.

What is AxoGen's EPS forecast for next year?

AxoGen's earnings are expected to grow from ($0.63) per share to ($0.41) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:AXGN) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -